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ABSTRACT
Here we present the development of a visual evaluation system for routine assessment of in vitro–en-
gineered cartilaginous tissue. Neocartilage was produced by culturing human articular chondrocytes
in pellet culture systems or in a scaffold-free bioreactor system. All engineered tissues were embedded in
paraffin and were sectioned and stained with Safranin O–fast green. The evaluation of each sample was
broken into 3 categories (uniformity and intensity of Safranin O stain, distance between cells/amount of
matrix produced, and cell morphology), and each category had 4 components with a score ranging from 0
to 3. Three observers evaluated each sample, and the new system was independently tested against an
objective computer-based histomorphometry system. Pellets were also assessed biochemically for gly-
cosaminoglycan (GAG) content. Pellet histology scores correlated significantly with GAG contents and
were in agreement with the computer-based histomorphometry system. This system allows a valid and
rapid assessment of in vitro–generated cartilaginous tissue that has a relevant association with objective
parameters indicative of cartilage quality.
INTRODUCTION
ARTICULAR CARTILAGE REPAIR using cell-based methodshas been the subject of much interest, with auto-
logous chondrocyte implantation (ACI), the leading clinical
strategy in humans.1–3 The increased number of published
works in various animal models over the past 10 years
reflects efforts to prefabricate implantable neocarti-
lage.4–10 With such activity, means to assess the repair
success using histological grading systems have been de-
veloped.11–13
Although these accepted grading systems have been used
extensively for the assessment of cartilage repair, they are not
readily applicable to the assessment of tissue-engineered
cartilage and pellet cultures. Many research laboratories
conducting basic studies of chondrogenesis using chondro-
cytes or mesenchymal stem cells employ pellet cultures,
especially where human cells are in rare supply or multi-
ple variables with expensive growth factors need to be
screened.14–18
Assessing the quality of tissue-engineered constructs is
routinely conducted using a range of techniques. Histological
analysis is essential to assess the structure of the neo-tissue
and to visualize the extent and components of extracellular
matrix produced.19 Immunohistochemical, biochemical, bio-
mechanical, and specific gene-expression studies are also
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employed to augment these assessments. The 2 most de-
finable elements used to study articular cartilage consist of
the presence of collagen type II and glycosaminoglycans
(GAGs). Although collagen type II has been used to assess
the differentiation state of the resident chondrocytes,20
GAG has been used frequently to assess many aspects of
cartilage status, including cartilage degradation,21–23 carti-
lage quality,11–13 and chondrogenic capacity,24 and as a
guide to extracellular matrix maturity.5
Safranin O intensity positively correlates with the GAG
content measured using biochemical analysis of 35S-labeled
cartilage or fixed charge density.25–27 Consequently, the
staining intensity of Safranin O has been used in many
computerized image analyses of cartilage28–31 and in vitro–
cultivated tissue.32,33 Indeed, Martin et al.32 measured the
intensity and the spatial distribution of red in Safranin O–
stained sections of engineered cartilage. The intensity of
stain was found to be in proportion to the wet weight frac-
tion of GAG.
O’Driscoll et al.33 tested the validity of a subjective
histological–histochemical scoring system based on the
visual estimation of percentage of cartilage alone, and com-
pared it with a previously developed objective automated
histomorphometry program.34 Although the objective sys-
tem in this study was preferred, the subjective grading of
the percentage cartilage was deemed valid. This system,
however, does not account for other features frequently
seen in engineered tissue, such as different cell morphol-
ogies present and the non-uniformity or heterogeneity of
the matrix products represented. Assessment of such phe-
nomenon may be of interest for fine-tuning techniques (e.g.,
cell culture environments) and may also influence the suc-
cess of engineered tissue once implanted into cartilage
defects.
In this current study, we aimed to develop a visual
scoring system (Bern Score) that may be used as a re-
ference for researchers to grade cartilaginous pellet cultures
and engineered tissue. We also developed the scoring sys-
tem to take into account features such as cell morphology
and construct heterogeneity. To validate this system, we
tested the graded tissue against a biochemical index (GAG
content) and the computer-based histomorphometric sys-
tem described by O’Driscoll et al.34
MATERIALS AND METHODS
Chondrocyte isolation and expansion
Human articular cartilage was obtained from 40 cadavers
under local ethical approval within 24 h post mortem.
Chondrocytes were released via enzymatic digestion with
0.15% type II collagenase for 22 h and expanded for
2 passages. Cells for pellet cultures were expanded in
Dulbecco’s modified Eagle medium (DMEM) with 10%
fetal calf serum, supplemented with transforming growth
factor b1, fibroblast growth factor 2, and platelet-derived
growth factor bb for approximately 2 weeks (see Barbero et
al.24 for details). Only DMEM with 10% fetal calf serum
was used to expand cells for seeding into the scaffold-
free bioreactor system.35
Pellet cultures. Post-expanded chondrocytes were placed
in pellet cultures using a defined serum-free medium, as
previously described.24 In summary, cells were suspended in
DMEM supplemented with ITSþ1 (Sigma Chemical, St.
Louis, MO), 107 M dexamethasone (Sigma), and 10 ng/mL
transforming growth factor b1 (R&D Systems, Minneapolis,
MN). Aliquots of 5105 cells/0.5 mL were centrifuged at
1200 rpm for 5 min in 1.5 mL polypropylene conical tubes
(Sarstedt, Nu¨mbrecht, Germany) to form spherical pellets,
which were placed onto a 3-dimensional orbital shaker
(Bioblock Scientific, Frenkendorf, Switzerland) at 30 rpm.
Pellets were cultured for 2 weeks, with medium changes
twice per week, and assessed histologically (Safranin O–fast
green staining) and biochemically (GAG content). Typi-
cally, 2 pellets were used for each assay for direct compar-
ison between these 2 parameters.
Biochemical Evaluation. For the assessment of total
GAG content of pellet cultures, each sample was first di-
gested with protease K (0.5 mL of 1 mg/mL protease K in
50 mM Tris with 1 mM ethylenediaminetetraacetic acid,
1 mM iodoacetamide, and 10 mg/mL pepstatin-A for 15 h at
568C).36 GAG quantity was measured spectrophotome-
trically using dimethylmethylene blue,37 with chondroitin
sulfate as a standard, and normalized to the deoxyribo-
nucleic acid (DNA) amounts, measured spectrofluoro-
metrically using the CyQUANT Kit (Molecular Probes,
Eugene, OR) and with calf thymus DNA as a standard. GAG
contents are reported as mgGAG/mgDNA.
Production of engineered neocartilage. Post-expanded
chondrocytes were cultured in a scaffold-free bioreactor
system as previously described for porcine chondrocytes.35
Briefly, 8106 cells were seeded into bioreactor chambers
and maintained within the reactor for 3 weeks in the same
media used for expansion, with media changes every 3 to
4 days. Subsequently, the formed cartilaginous tissues were
removed and placed in culture media, each in 1 well of a 6-
well plate, and further cultured for 1 week. After cultivation
time, the neocartilage was fixed in 4% paraformaldehyde
and embedded in paraffin for archive storage. For the
current study, the paraffin blocks were retrieved for staining
with Safranin O–fast green.
Safranin O–fast green staining
Paraffin-embedded tissues (pellet and engineered) were
sliced at 3 to 4 mm and mounted on glass slides (Super Frost
color, Menzel-Gla¨ser, Freiburg, Germany). The paraffin
slices were immersed in xylene, twice for 5 min, to remove
paraffin and then re-hydrated in an alcohol series (twice
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100%, 95%, and 70%; 2 min each) and finally in distilled
water for 5 min. For Safranin O staining (0.2 g Safranin T,
Fluka, Buchs, Switzerland; 1 mL 100% acetic acid; 100 mL
distilled water), the slides were immersed in the Safranin
solution for 10 min followed by rinsing in distilled water.
The sections were then further stained in fast green solution
(0.04 g fast green chroma; 0.2 mL 100% acetic acid;
100 mL distilled water) for 15 s, rinsed in distilled water,
and dried between filter paper. Subsequently, the slides
were rinsed in absolute alcohol until excess fast green was
removed, whereupon the Safranin O staining becomes
apparent. After 2 washes in xylene (5 min each), a cover
slip with Eukitt was placed over the stained tissue. The
quality of Safranin O–fast green staining is routinely
monitored with reference tissues of osteoarthritis (OA),
normal, and growth-plate cartilage to reduce variations in
staining intensities. The reagents used in this staining
procedure must also be changed regularly (every 50 to 100
slides).
Histology grading
Examination. Each observer evaluated pellet culture
(n¼ 25) and tissue-engineered sections (n¼ 20) stained
with Safranin O–fast green under a light microscope (Ax-
ioskop, Zeiss, Germany) using the Bern Score system as
described below. Each observer (1 pathologist and 2 basic
scientists, experienced in the examination of engineered
cartilage) graded each sample twice (pellet cultures and
tissue-engineered cartilage) with an interval of 3 months
between evaluations.
Grading Safranin O–fast green stained slides using the
Bern Score. The Bern Score accounts for uniformity and
intensity of matrix staining, cell density/extent of matrix
produced, and cellular morphologies. Table 1 details the 3
criteria, each with equal weight, with a possible mini-
mum collective score of 0 and a maximum of 9. Sections
were scored 1 category at a time and added to give a total
score.
Category A: Uniformity and darkness of Safranin O–fast
green stain. Each sample was observed with a 10objective.
Category B: Distance between cells/amount of matrix
accumulated was assessed with a 20objective. Most neo-
cartilage material is more highly cellular than native car-
tilage, but it is possible to distinguish differences in cellular
distributions in pellet and tissue-engineered cartilage.
Category C: Cellular morphologies were viewed using a
40objective. Based on the general consensus that a rounded
cellular morphology is indicative of a chondrocyte pheno-
type, the presence of pyknotic/necrotic or fibroblast morpho-
logies was interpreted to represent a negative quality and
was scored accordingly.
The categories chosen in the Bern Score are likely to be
interrelated. For instance, more-fibroblastic cells typically
deposit matrix weakly stained for Safranin O.
Computer histomorphometric analysis
Pellet culture (n¼ 25) and tissue-engineered sections
(n¼ 20) that were graded using the Bern Score were also
graded blindly using computerized histomorphometry to
determine what proportion of the tissue produced was car-
tilage (percentage cartilage yield). These evaluations were
performed with a custom-designed software application
using the Vidas 2.1 Image Analysis System (Kontron cus-
tomized by Carl Zeiss Canada, Don Mills, Ontario, Cana-
da), which was previously validated for automated cartilage
histomorphometry on periosteal explants.33 The analysis of
cartilage is conducted automatically without the need of
any manual ‘‘tracing’’ and is based on the uptake of Sa-
franin O stain, with the thresholds and combinations of red,
green, and blue distinguished automatically. The software
algorithm discriminated each region (cartilaginous and non-
cartilaginous) based on its color.
Photomicrographs
Images of Safranin O–fast green stained sections of
pellet cultures and engineered tissues used for the visual
scales were captured using a microscope (Axiophot2, Ziess,
Germany) fitted with a digital camera (Axiocam, Ziess,
Germany) using 5, 10, 20, and 40 objectives.
TABLE 1. THE BERN SCORE: FOR THE EVALUATION OF
SAFRANIN O–FAST GREEN STAINED CARTILAGINOUS PELLET
CULTURES AND ENGINEERED TISSUE SECTIONS (MINIMUM
SCORE: 0; MAXIMUM SCORE: 9)
Scoring categories Score
A. Uniformity and darkness* of Safranin O–fast
green stain
No stain 0
Weak staining of poorly formed matrix 1
Moderately even staining 2
Even dark stain 3
B. Distance between cells/amount of matrix
accumulated
High cell densities with no matrix in between (no
spacing between cells)
0
High cell densities with little matrix in between
(cells <1 cell-size apart)
1
Moderate cell density with matrix (cells approx. 1
cell-size apart)
2
Low cell density with moderate distance between
cells (>1 cell) and an extensive matrix
3
C. Cell morphologies represented
Condensed/necrotic/pycnotic bodies 0
Spindle/fibrous 1
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Statistical analysis
To test for correlations between the Bern Score and the
computer-based histomorphometric system or between the
Bern Score and the GAG content of pellet cultures, re-
gression analysis was performed using Microsoft Excel97
(Microsoft Corp., Redmond, WA). Intra- and inter-
observer reproducibility was calculated as described by
Moojen et al.38 The intra-observer reliability was generated
from the difference of the 2 scores from a given observer
and the mean of that section. Inter-observer reliability was
derived from the difference between observer scores for a
specific section and the average for that tissue sample.
RESULTS
From the pellet culture samples and engineered tissue
constructs processed in this study, and from other archival
material, we identified a variety of histological images (Fig.
1) that span the range of qualities normally produced in our
hands using the 2 culture systems described in this study.
Figure 1 represents images of Safranin O–fast green pellet
cultures and tissue-engineered cartilage, from the generated
paraffin block archive, that may be used as a visual re-
ference for other researchers who are also interested in
assessing the quality of neocartilage produced in their
systems. Table 2 provides an overview of scores for each
category to further illustrate the use of the Bern Score. As a
convention, in situations in which a score in a particular
category may be thought to be between the criteria outlined
by the Bern Score, the grader should choose the upper
score. A group consensus session after individual scoring
may also be effective in adjudicating some difficult-to-
grade sections, especially those with multiple regions.
Representative examples of necrotic/pyknotic and fibro-
blast cellular morphologies, particularly observed in pellet
FIG. 1. Representative Safranin O–fast green images of (A) pellet cultures and (B) engineered cartilaginous tissue as a visual guide to
scoring such cartilaginous tissues using the Bern Score provided in Table 1. The breakdown of these scores using the Bern Score is
presented in Table 2 (magnification 40). Color images available online at www.liebertpub.com/ten.
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cultures, are depicted in Fig. 2. Most neocartilage formed in
this study was homogenous with respect to the categories
used in the Bern Score. However, in some constructs there
was a heterogenous mixture of staining intensities and cell
morphologies represented. An example of this phenomenon
is illustrated in Fig. 3. In this field, there are at least 4
regions represented, and depending on the location, a score
ranging from 4 to 9 may be given. To overcome this di-
lemma, we propose to identify each region, estimate the
area it represents (as a percentage of the total area), and
score each region individually. Each individual score is
then adjusted with respect to the percentage area re-
presented, and all scores are added together (100%) to
provide an overall single score (see example in Fig. 3).
A significant correlation between the Bern Score and the
computer-based histomorphometric system was established
for pellet cultures (r2¼ 0.63; p< 0.001; n¼ 25) and tissue-
engineered neocartilages (r2¼ 0.69; p< 0.001; n¼ 20).
Pellet and tissue-engineered cartilage scores are presented
in Fig. 4A (r2¼ 0.68; p< 0.0001; n¼ 45). The Bern Scores
were also found to significantly correlate (r2¼ 0.78;
p< 0.001; n¼ 40) with the biochemical attributes (GAG
content) of pellet cultures (Fig. 4B). The intra-observer and
inter-observer reproducibility is summarized in Table 3. The
mean overall intra-observer and inter-observer reproduc-
ibility were 0.06 1.05 and 0.06 0.17, respectively.
DISCUSSION
We have developed a visual histological grading system
for the assessment of engineered cartilaginous tissues that
correlates positively with computerized histomorphometry
and biochemical measurements. The previously reported
relationship between GAG content and pro-collagen type II
gene expression24 further validates the described system.
The Bern Score is unique in that it not only grades car-
tilage per se, but also gives weight to non-cartilage-like
areas that may be of interest to some investigators and
prove important for the prediction of implant success. Re-
cording and assessing the quality of neocartilage in this
manner may be a basis to determine the effect of in vitro
culture techniques and supplements on the development of
cartilaginous tissues. The users of this system should define
clearly what information is needed and compatible with an
end goal. For instance, averaging scores for a general ac-
count of chondrogenesis may be compatible with adjusting
culture conditions but not when grading engineered im-
plants in which the presence of any necrotic tissue is not
considered acceptable. The purpose of the images re-
presented in this manuscript (Figs. 1 and 2) may aid other
researchers in cartilage tissue engineering who wish to
assess the quality of their engineered tissue. Additionally,
we hope that the Bern Score will, at the very least, stimu-
late discussion in reaching a consensus or lead toward the
development of a common language and system to evaluate
such in vitro–generated tissues.
For the assessment of heterogeneous samples (i.e., sec-
tions with multiple cellular morphologies), we suggested a
re-weighting approach that requires the scorer to estimate
the percentage area represented by each region. In most
instances, we found this method to be relatively straight-
forward, but in cases in which it may be difficult to discern
percentage areas, we recommend group consensus scoring
on those samples or on samples that show large inter-
individual variation. It may also be beneficial to have at
least one trained pathologist to assist in such consensus
scoring because this is a standard practice in pathology.
Other criteria commonly recognized as characteristic of
cartilage might have been chosen in this system. Collagen
TABLE 2. BREAKDOWN OF GRADES OF PELLET AND ENGINEERED













Pellet (Ai) 0 0 0 0
Engineered (Bi) 0 0 0 0
Pellet (Aii) 1 1 0 2
Engineered (Bii) 1 1 1 3
Pellet (Aiii) 1 2 2 5
Engineered (Biii) 2 2 2 6
Pellet (Aiv) 2 2 2 6
Engineered (Biv) 2 2 3 7
Pellet (Av) 2 3 2 7
Engineered (Bv) 3 3 2 8
Pellet (Avi) 3 3 2 8
Engineered (Bvi) 3 3 3 9
FIG. 2. Examples of pyknotic/necrotic (A) and fibrous type (B)
morphologies found in engineered cartilage tissues (magnifica-
tions: i¼ 10; ii¼ 40).
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type II immunohistochemistry and Alcian blue staining
were considered, but to keep the approach as simple as
possible, Safranin O–fast green was selected because of
its previously demonstrated correlation with other meth-
ods.25–27 Alcian blue has been reported to be a less reliable
means of assessing proteoglycan content, producing
variability in staining intensities and localities that cannot
be entirely explained.19 Although collagen type II is widely
recognized as a definitive attribute of cartilage, pellet cul-
tures and most engineered cartilages are immature and have
low collagen contents,37,39 at least at the protein level at
this stage, and thus GAG (a dominant molecule in such
tissue) is perhaps more appropriate. Furthermore, re-
producible immunolocalization of collagens is not a straight-
forward approach and is more expensive than most
standard histological staining protocols. If the engineered
constructs have been matured in culture or have been me-
chanically conditioned, then collagen quantifications may
be of interest. Sirus Red may be a stain to consider and
include in the total score because it has been shown to
FIG. 3. Non-homogenous construct stained with Safranin O–fast green. Four regions are represented in this sample. (A) Overview
with the distinct regions indicated. The rounded morphology, intensive stain, and cellular distance in (B) is approximately 50% (Grade
9), the morphology and staining intensity in (C) is approximately 20% (Grade 6), the reduced stained region located in (D) consists of
approximately 20% (Grade 8), and the low stained and fibrous tissue in (E) is approximately 10% of the whole construct (Grade 4).
Thus, this construct could be graded from 4 to 9 depending on where one chooses to grade. To score giving weight to the proportion, the
scores are altered by the percentage area represented (i.e., (90.5þ 60.2þ 80.2þ 40.1)¼ 7.7). Recording the presence of the
fibrous tissue may be important when considering the use of such material for in vivo cartilage repair (magnifications: A¼ 10;
B–E¼ 40). Color images available online at www.liebertpub.com/ten.
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allow differentiation between collagen subtypes when ob-
served under polarized light.40 Nevertheless, the Bern
Score may be interpreted as a ‘‘modular’’ system that could
allow for other criteria to be added to its existing frame-
work.
Although all tissues in this study were produced without
the means of scaffolds, we believe that the Bern Score would
be valid in systems that employ them. The cellular and
matrix components of any cartilaginous-engineered con-
structs should be the main focus on the assessment of tissue
quality. However, if there were particular reactions of the
cells to a given scaffold, the Bern Score may be a means to
record these in terms of overall neo-tissue quality, the
amount of matrix produced, the GAG content, and the re-
sulting cellular morphologies represented.
CONCLUSION
Here we provide a visual scoring system that will be
helpful in guiding other researchers who also need to assess
chondrogenic environments. Although this system is sub-
jective in nature, it correlated with 2 other objective para-
meters (biochemical and an automated computer-based
histomorphometric system). The Bern Score provides an
account of cell distribution and resident cell morphologies
that is as descriptive as that of the established methods.
Moreover, this method might be appropriate in settings that
do not have access to sophisticated histomorphometric
systems. Future efforts will aim at establishing whether
particular scores and morphological features in engineered
cartilaginous tissue may relate to the in vivo capacity to
support successful repair of an articular defect.
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